202 related articles for article (PubMed ID: 33773564)
1. Promoter Hypermethylation of LATS1 Gene in Oral Squamous Cell Carcinoma (OSCC) among North Indian Population.
Goel H; Mathur R; Syeda S; Shrivastava A; Jha AK
Asian Pac J Cancer Prev; 2021 Mar; 22(3):977-982. PubMed ID: 33773564
[TBL] [Abstract][Full Text] [Related]
2. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India.
Reddy VR; Annamalai T; Narayanan V; Ramanathan A
Asian Pac J Cancer Prev; 2015; 16(4):1599-603. PubMed ID: 25743838
[TBL] [Abstract][Full Text] [Related]
4. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
5. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
7. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation in Indian primary oral squamous cell carcinoma.
Kaur J; Demokan S; Tripathi SC; Macha MA; Begum S; Califano JA; Ralhan R
Int J Cancer; 2010 Nov; 127(10):2367-73. PubMed ID: 20473870
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of miR-34b/c DNA methylation, gene expression, and promoter polymorphism in HPV-negative oral squamous cell carcinomas.
Supic G; Stefik D; Ivkovic N; Sami A; Zeljic K; Jovic S; Kozomara R; Vojvodic D; Stosic S
Sci Rep; 2022 Jan; 12(1):1296. PubMed ID: 35079080
[TBL] [Abstract][Full Text] [Related]
10. An Insight into Survivin in Relevance to Hematological, Biochemical and Genetic Characteristics in Tobacco Chewers with Oral Squamous Cell Carcinoma.
Yesupatham ST; Dayanand CD; Azeem Mohiyuddin SM; Harendra Kumar ML
Cells; 2023 May; 12(10):. PubMed ID: 37408277
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma.
Khor GH; Froemming GR; Zain RB; Abraham MT; Omar E; Tan SK; Tan AC; Vincent-Chong VK; Thong KL
Int J Med Sci; 2013; 10(12):1727-39. PubMed ID: 24155659
[TBL] [Abstract][Full Text] [Related]
12. TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
Puttipanyalears C; Arayataweegool A; Chalertpet K; Rattanachayoto P; Mahattanasakul P; Tangjaturonsasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
BMC Cancer; 2018 Aug; 18(1):786. PubMed ID: 30081853
[TBL] [Abstract][Full Text] [Related]
13. Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa.
Kato K; Hara A; Kuno T; Mori H; Yamashita T; Toida M; Shibata T
J Cancer Res Clin Oncol; 2006 Nov; 132(11):735-43. PubMed ID: 16791592
[TBL] [Abstract][Full Text] [Related]
14. Association of Interleukin-10 (A1082G) gene polymorphism with Oral squamous cell carcinoma in north Indian population.
Hussain SR; Ahmad MK; Mahdi AA; Naqvi H; Ahmad MW; Srivastava S; Nigam K; Gupta S
J Genet; 2016 Jun; 95(2):249-55. PubMed ID: 27350666
[TBL] [Abstract][Full Text] [Related]
15. Global and promoter specific hypermethylation of tumor suppressor genes P16, SOCS1, and SHP1 in oral squamous cell carcinoma and oral submucous fibrosis.
Ukey S; Jain A; Dwivedi S; Vishnoi JR; Chugh A; Purohit P; Pareek P; Elhence P; Misra S; Sharma P
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S551-S559. PubMed ID: 38384018
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter methylation of PTEN gene among Indian
patients with oral squamous cell carcinoma.
Alyasiri NS; Ali A; Kazim Z; Gupta S; Mandal AK; Singh I; Rizvi MA
Int J Biol Markers; 2013 Sep; 28(3):298-302. PubMed ID: 23787493
[TBL] [Abstract][Full Text] [Related]
17. BRD7 promoter hypermethylation as an indicator of well differentiated oral squamous cell carcinomas.
Balasubramanian A; Subramaniam R; Narayanan V; Annamalai T; Ramanathan A
Asian Pac J Cancer Prev; 2015; 16(4):1615-9. PubMed ID: 25743841
[TBL] [Abstract][Full Text] [Related]
18. Contribution of LATS1 and LATS2 promoter methylation in OSCC development.
Ladiz MA; Najafi M; Kordi-Tamandani DM
J Cell Commun Signal; 2017 Mar; 11(1):49-55. PubMed ID: 27761802
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer.
Noorlag R; van Kempen PM; Moelans CB; de Jong R; Blok LE; Koole R; Grolman W; van Diest PJ; van Es RJ; Willems SM
Epigenetics; 2014 Sep; 9(9):1220-7. PubMed ID: 25147921
[TBL] [Abstract][Full Text] [Related]
20. Validation of methylation markers for diagnosis of oral cavity cancer.
Arantes LM; de Carvalho AC; Melendez ME; Centrone CC; Góis-Filho JF; Toporcov TN; Caly DN; Tajara EH; Goloni-Bertollo EM; Carvalho AL;
Eur J Cancer; 2015 Mar; 51(5):632-41. PubMed ID: 25686481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
